Questionnaire (Adult)
OtherPatients and case control will have to respond to the study questionnaire on the online entry platform to compare the distribution of socio-professional categories.
Answering the questionnaires will take 45 minutes.
NCT Number: NCT03765892
Narcolepsy is a chronic, disabling, and rare sleep disorder (prevalence 1/2500) characterized by excessive daytime sleepiness and, in some patients, falls in muscle tone related to emotions (cataplexies). It often begins in childhood or in young adults. Symptoms of narcolepsy are responsible for an important handicap in everyday life, and are often misunderstood by the family and professional environment. In addition, many comorbidities are associated with narcolepsy, such as depression, anxiety, or obesity.
Few studies have investigated the impact of narcolepsy on patients' academic background, socio-professional integration, and quality of life.
Narcoleptic patients may experience more difficulties in their academic and professional path than non-narcoleptic people. These difficulties would be multifactorial (related to the disease itself, comorbidities, external factors ...).
As a better understanding of these determinants could help to inform patients and guide them in their choices, this study propose to establish a comprehensive inventory of educational and professional trajectories of narcoleptic patients in France in order assess the specificity of the difficulties encountered by the people concerned in their life course and to appreciate the attitude of the academic and professional circle with respect to the disease.
This category 3 study (according to the French law "Loi Jardé") is based on the case-control model and will be conducted in all National Reference and Competence Centers for Narcolepsy and Hypersomnia. It will include a population of adult and paediatric patients. It will answer questions about work and schooling in these patients.
Looking for future studies?
Notify Me6 year and older
All sexes
Observational
Centre de médecine du Sommeil CHU d'Angers, Angers, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
The case group:
The control group:
Exclusion criteria
The case group:
The group controls:
Patients and case control will have to respond to the study questionnaire on the online entry platform to compare the distribution of socio-professional categories.
Answering the questionnaires will take 45 minutes.
Patients and case control will have to respond to the study questionnaire on the online entry platform to compare the proportion of subjects having repeated grades.
Answering the questionnaires will take 45 minutes.
Time frame: 45 minutes (time to answering the questionnaire)
Distribution of professional situations in narcoleptic adult patients and related non-narcoleptic topics (employed, unemployed, student, retired, housewife/husband). (data collection form "professional situation").
Time frame: 45 minutes (time to answering the questionnaire)
Proportion of children who repeated a grade in narcoleptic children and non-narcoleptic control children ("school status" data collection form).
Hospices Civils de Lyon
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05615584
Cataplexy, Disorders of Excessive Somnolence
Montpellier, France
View Trial DetailsNCT05709873
Disorders of Excessive Somnolence, Dyssomnias
Chicago, Illinois, United States
View Trial DetailsNCT03881852
Cataplexy, Cataplexy Narcolepsy
Birmingham, Alabama, United States
View Trial DetailsNCT06586138
Anxiety Disorders, Apnea
Lyon, France
View Trial Details